acetylcysteine has been researched along with Cardiovascular Diseases in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (50.00) | 29.6817 |
| 2010's | 15 (41.67) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Cheng, M; Fan, L; Guo, Y; Liang, R; Liu, W; Ma, J; Qiu, W; Song, J; Wang, B; Wang, D; Wang, X; Yang, M; Yu, L; Zhou, M | 1 |
| Cao, Y; Chen, Z; Cheng, D; Li, X; Wang, X; Wu, Y; Xie, X; Yang, B; Yu, J; Zhou, J | 1 |
| Huang, CH; Jiang, SJ | 1 |
| Dias, SC; Dludla, PV; Johnson, R; Louw, J; Nkambule, BB; Obonye, N | 1 |
| Damdindorj, L; Hosokawa, Y; Hossain, E; Karnan, S; Konishi, H; Konishi, Y; Ota, A; Takahashi, M | 1 |
| Lynch, C; Potter, A; Seefeldt, T; Xie, J; Xie, W | 1 |
| Abplanalp, W; Becher, C; Bhatnagar, A; Chugh, A; Ciszewski, T; Conklin, DJ; DeFilippis, A; DeJarnett, N; Hamzeh, I; Higdon, D; McCracken, J; Myers, JA; O'Toole, TE; Prabhu, SD; Rai, SN; Ramos, KS; Riggs, DW; Srivastava, S; Tollerud, DJ; Wagner, S; Wyatt, B; Xie, Z; Yeager, R | 1 |
| Antonilli, L; Badiani, A; Grassi, MC; Graziani, M; Saso, L; Togna, AR | 1 |
| Durante, W; Durante, ZE; Liu, XM; Peyton, KJ | 1 |
| Adabag, AS; Bloomfield, HE; Chandrashekhar, Y; Ishani, A; Johnson, DJ; Kelly, RF; Koneswaran, S; McFalls, EO; Ward, HB | 1 |
| Albini, A; Cammarota, R; De Flora, S; Donatelli, F; Noonan, DM; Pennesi, G | 1 |
| Aleksandrowicz, E; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Łysiak-Szydłowska, W | 1 |
| Gao, S; Kim, SH; Oh, YB; Park, WH; Shah, A | 1 |
| Coombes, JS; Fassett, RG | 1 |
| De Santo, NG; Ingrosso, D; Lanza, D; Perna, AF; Pollastro, RM; Sepe, I | 1 |
| Anderson-Hunt, M; Berk, M; Bush, AI; Copolov, DL; Dean, OM; Jeavons, S; Kohlmann, K; Magalhães, PV; Malhi, GS; Schapkaitz, I; Weisinger, D | 1 |
| Barr, C; Barrett, F; Dransfield, I; Mackenzie, I; MacRury, SM; Megson, IL; Rushworth, GF; Treweeke, AT; Winterburn, TJ | 1 |
| Cacciapuoti, F | 1 |
| Jain, SK; Kanikarla-Marie, P; Rains, JL | 1 |
| Allaqaband, S; Bajwa, TK; Gupta, A; Malik, AM; Shalev, Y; Tumuluri, R; Volkert, P | 1 |
| Brinker, JA | 1 |
| Jankowski, J; Statz, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Brizendine, EJ; Furbee, RB; Kao, LW; Kirk, MA; Mehta, NH; Skinner, JR | 1 |
| Robinson, K | 1 |
| Chan, AK; Chan, JY; Chan, WW; Fung, JW; Kum, LC; Sanderson, JE; Szeto, CC; Wong, JT; Woo, KS; Wu, EB; Yip, GW; Yu, CM | 1 |
| Cai, W; He, JC; Lu, C; Peppa, M; Uribarri, J; Vlassara, H; Zhu, L | 1 |
| Tepel, M; Zidek, W | 1 |
| Allada, CS; Dias, L; Keogh, AM; Kotlyar, E; Muller, D; Sharp, J; Thavapalachandran, S | 1 |
| Aitio, ML | 1 |
| Matkovics, A | 1 |
| Coderre, L; Pelletier, A | 1 |
| Scheller, B | 1 |
| Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Colombo, A; Cosgrave, J; D'Andrea, D; Focaccio, A; Michev, I; Montorfano, M; Morici, N; Ricciardelli, B | 1 |
| Akcar, N; Sahin, G; Yalcin, AU | 1 |
| Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
| Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
10 review(s) available for acetylcysteine and Cardiovascular Diseases
| Article | Year |
|---|---|
The Clinical Efficacy of N-Acetylcysteine in the Treatment of ST Segment Elevation Myocardial Infarction.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Creatine Kinase, MB Form; Female; Free Radical Scavengers; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Stroke Volume; Treatment Outcome; Troponin T | 2021 |
A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Protective Agents | 2018 |
Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiovascular Diseases; Catecholamines; Cattle; Cocaine; Humans; Liver; Male; Mice; Mitochondria; Myocytes, Smooth Muscle; NADPH Oxidases; Nitrogen Oxides; Oxidative Stress; Rats; Reactive Oxygen Species; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Xanthine Oxidase | 2016 |
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Blood Coagulation; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Flavonoids; Free Radical Scavengers; Heart; Humans; Hypertension; Patient Care Team; Phenols; Platelet Aggregation Inhibitors; Polyphenols; Stroke Volume; Venous Thromboembolism; Ventricular Dysfunction, Left | 2010 |
Antioxidant therapy in hemodialysis patients: a systematic review.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Oxidative Stress; Renal Dialysis; Vitamin E | 2012 |
Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
Topics: Acetylcysteine; Cardiovascular Diseases; Drug Resistance; Folic Acid; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Risk Factors | 2012 |
N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Contrast Media; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic | 2004 |
N-acetylcysteine -- passe-partout or much ado about nothing?
Topics: Acetylcysteine; Anti-HIV Agents; Antioxidants; Cardiovascular Diseases; Drug Therapy, Combination; Expectorants; HIV Infections; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Neoplasms; Oxidative Stress; Reactive Oxygen Species | 2006 |
[Recent changes in concepts of antioxidant treatment].
Topics: Acetylcysteine; Allopurinol; Antioxidants; Apoptosis; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Coenzymes; Flavonoids; Humans; Meta-Analysis as Topic; Neoplasms; Selenium; Ubiquinone; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins | 2006 |
How to protect from contrast media-induced nephropathy?
Topics: Acetylcysteine; Acute Kidney Injury; Angiography; Cardiovascular Diseases; Contrast Media; Free Radical Scavengers; Humans; Risk Assessment; Risk Factors | 2007 |
11 trial(s) available for acetylcysteine and Cardiovascular Diseases
| Article | Year |
|---|---|
Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cardiovascular Diseases; Creatinine; Double-Blind Method; Female; Humans; Male; Perioperative Care; Treatment Outcome | 2008 |
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Albuminuria; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Diabetes Complications; Female; Free Radical Scavengers; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Placebos; Proteins; Risk Factors; Sodium; Young Adult | 2010 |
Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder.
Topics: Acetylcysteine; Adult; Bipolar Disorder; Cardiovascular Diseases; Double-Blind Method; Endocrine System Diseases; Female; Free Radical Scavengers; Humans; Inflammation; Male; Middle Aged; Oxidative Stress | 2012 |
N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Blood Platelets; Cardiovascular Diseases; Cell Communication; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Free Radical Scavengers; Glutathione; Humans; Hypoglycemic Agents; Male; Middle Aged; Monocytes; Placebos | 2012 |
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Creatinine; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sodium Chloride; Stroke Volume; Treatment Outcome | 2002 |
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Survival Analysis; Treatment Outcome | 2003 |
Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiovascular Diseases; Comorbidity; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency; Urea | 2004 |
High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.
Topics: Acetylcysteine; Administration, Oral; Antioxidants; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Male; Middle Aged; NADPH Oxidases; NF-kappa B; Oxidation-Reduction; Transcriptional Activation; Vascular Cell Adhesion Molecule-1 | 2004 |
Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures--a randomised controlled trial.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angiography; Cardiovascular Diseases; Contrast Media; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Fluid Therapy; Free Radical Scavengers; Humans; Infusions, Intravenous; Iohexol; Kidney Diseases; Kidney Function Tests; Male; Middle Aged | 2005 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Diseases; Male; Renal Insufficiency; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome; Triiodobenzoic Acids | 2007 |
Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients.
Topics: Acetylcysteine; Adult; Antioxidants; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Female; Hemorheology; Humans; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidative Stress; Renal Dialysis; Ultrasonography; Uremia; Vasodilation | 2007 |
15 other study(ies) available for acetylcysteine and Cardiovascular Diseases
| Article | Year |
|---|---|
Acrylamide exposure increases cardiovascular risk of general adult population probably by inducing oxidative stress, inflammation, and TGF-β1: A prospective cohort study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Acrylamide; Adult; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Heart Disease Risk Factors; Humans; Inflammation; Oxidative Stress; Prospective Studies; Risk Factors; Transforming Growth Factor beta1 | 2022 |
Association between urinary metabolites of volatile organic compounds and cardiovascular disease in the general population from NHANES 2011-2018.
Topics: Acetylcysteine; Cardiovascular Diseases; Humans; Nutrition Surveys; Volatile Organic Compounds | 2023 |
Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells.
Topics: Acetylcysteine; Animals; Anthracenes; Aorta; Arsenites; Cardiovascular Diseases; Cell Line; Cell Proliferation; Endothelium, Vascular; Environmental Pollutants; Enzyme Inhibitors; Free Radical Scavengers; Mice; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Sodium Compounds; Up-Regulation | 2013 |
Evaluation of a dithiocarbamate derivative as a model of thiol oxidative stress in H9c2 rat cardiomyocytes.
Topics: Acetylcysteine; Animals; Cardiovascular Diseases; Cell Line; Glutathione; Glutathione Disulfide; Humans; Myocytes, Cardiac; Oxidative Stress; Rats; Sulfhydryl Compounds; Thiocarbamates | 2014 |
Acrolein exposure is associated with increased cardiovascular disease risk.
Topics: Acetylcysteine; Acrolein; Adult; Aged; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Humans; Kentucky; Leukocytes; Linear Models; Male; Middle Aged; Platelet Activation; Smoking | 2014 |
Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction.
Topics: Acetylcysteine; Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Cell Proliferation; Endothelial Cells; Gene Expression Regulation; Heme Oxygenase-1; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; NF-E2-Related Factor 2; Promoter Regions, Genetic; Reactive Oxygen Species; Ritonavir; Rotenone | 2016 |
Oxidative stress augments the secretion of atrial natriuretic peptide in isolated rat atria.
Topics: Acetylcysteine; Animals; Ascorbic Acid; Atrial Natriuretic Factor; Cardiovascular Diseases; Extracellular Fluid; Guanidines; Heart Atria; Hemodynamics; Hydrogen Peroxide; Male; Mitogen-Activated Protein Kinase Kinases; Myocardial Contraction; Organ Culture Techniques; Oxidative Stress; Propyl Gallate; Pyrogallol; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium-Hydrogen Exchangers; Sulfones | 2011 |
Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors.
Topics: Acetylcysteine; Aspirin; Blood Vessels; Cardiovascular Diseases; Clopidogrel; Diuretics; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Metformin; Platelet Aggregation Inhibitors; S-Adenosylmethionine; Ticlopidine; Vitamin B 12; Vitamin B 6 | 2012 |
Hyperketonemia induces upregulation of LFA-1 in monocytes, which is mediated by ROS and P38 MAPK activation.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetylcysteine; Cardiovascular Diseases; Cell Adhesion Molecules; Cells, Cultured; Humans; Ketosis; Lymphocyte Function-Associated Antigen-1; MAP Kinase Signaling System; Monocytes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Up-Regulation | 2012 |
The third strike.
Topics: Acetylcysteine; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Radiopharmaceuticals; Sodium Chloride | 2002 |
What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?
Topics: Acetaminophen; Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cardiovascular Diseases; Child; Child, Preschool; Drug Eruptions; Drug Hypersensitivity; Drug Interactions; Drug Overdose; Female; Free Radical Scavengers; Histamine H1 Antagonists; Humans; Indiana; Infant; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Diseases; Retrospective Studies; Survival Analysis | 2003 |
Renal disease, homocysteine, and cardiovascular complications.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors | 2004 |
Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes.
Topics: 2,4-Dinitrophenol; 3-Hydroxybutyric Acid; Acetyl-CoA Carboxylase; Acetylcysteine; AMP-Activated Protein Kinases; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Free Radical Scavengers; Glucose; Ketone Bodies; Male; Multienzyme Complexes; Myocytes, Cardiac; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Uncoupling Agents | 2007 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins | 2001 |